Aurinia Pharmaceuticals (AUPH) News Today $12.08 -0.03 (-0.25%) Closing price 04:00 PM EasternExtended Trading$11.99 -0.09 (-0.74%) As of 07:44 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock AUPH Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 Time Period Nuveen LLC Invests $10.01 Million in Aurinia Pharmaceuticals Inc $AUPHAugust 25 at 3:41 AM | marketbeat.comDeutsche Bank AG Has $2.03 Million Stock Position in Aurinia Pharmaceuticals Inc $AUPHAugust 24, 2025 | marketbeat.com76,328 Shares in Aurinia Pharmaceuticals Inc $AUPH Bought by EntryPoint Capital LLCAugust 22, 2025 | marketbeat.comAurinia Pharmaceuticals (NASDAQ:AUPH) Hits New 1-Year High - Here's What HappenedAugust 21, 2025 | marketbeat.comFox Run Management L.L.C. Has $361,000 Holdings in Aurinia Pharmaceuticals Inc $AUPHAugust 21, 2025 | marketbeat.comAurinia Pharmaceuticals (NASDAQ:AUPH) Reaches New 12-Month High - Time to Buy?August 15, 2025 | marketbeat.comConnor Clark & Lunn Investment Management Ltd. Increases Stock Holdings in Aurinia Pharmaceuticals Inc (NASDAQ:AUPH)August 14, 2025 | marketbeat.comInsider Buying: Aurinia Pharmaceuticals Inc (NASDAQ:AUPH) Director Buys 100,000 Shares of StockAugust 6, 2025 | marketbeat.comKevin Tang Acquires 200,000 Shares of Aurinia Pharmaceuticals Inc (NASDAQ:AUPH) StockAugust 6, 2025 | marketbeat.comAurinia Pharmaceuticals Inc (NASDAQ:AUPH) Director Kevin Tang Acquires 1,000,000 SharesAugust 6, 2025 | marketbeat.comAurinia Pharma: The Easiest Money May Have Been Made (Rating Downgrade)August 6, 2025 | seekingalpha.comInsider Buying: Aurinia Pharmaceuticals Inc (NASDAQ:AUPH) Director Purchases 100,000 Shares of StockAugust 6, 2025 | insidertrades.comAurinia Pharmaceuticals’ Earnings Call: Strong Growth and OptimismAugust 6, 2025 | theglobeandmail.comAurinia Pharmaceuticals (NASDAQ:AUPH) Reaches New 12-Month High After Analyst UpgradeAugust 5, 2025 | marketbeat.comJupiter Asset Management Ltd. Takes $6.05 Million Position in Aurinia Pharmaceuticals Inc (NASDAQ:AUPH)August 4, 2025 | marketbeat.comXTX Topco Ltd Purchases 63,681 Shares of Aurinia Pharmaceuticals Inc (NASDAQ:AUPH)August 4, 2025 | marketbeat.comResearch Analysts Set Expectations for AUPH FY2026 EarningsAugust 4, 2025 | marketbeat.comWhat is Leerink Partnrs' Forecast for AUPH Q1 Earnings?August 4, 2025 | marketbeat.comAurinia Pharmaceuticals Inc. (NASDAQ:AUPH) Just Beat EPS By 9.1%: Here's What Analysts Are Forecasting For This YearAugust 3, 2025 | uk.finance.yahoo.comAurinia Pharmaceuticals (NASDAQ:AUPH) Posts Earnings Results, Misses Expectations By $0.01 EPSAugust 3, 2025 | marketbeat.comGSA Capital Partners LLP Increases Position in Aurinia Pharmaceuticals Inc (NASDAQ:AUPH)August 3, 2025 | marketbeat.comAurinia Pharmaceuticals (NASDAQ:AUPH) Trading Up 6.1% Following Analyst UpgradeAugust 2, 2025 | marketbeat.comRoyal Bank Of Canada Increases Aurinia Pharmaceuticals (NASDAQ:AUPH) Price Target to $9.00August 2, 2025 | marketbeat.comEquities Analysts Offer Predictions for AUPH Q2 EarningsAugust 2, 2025 | marketbeat.comAurinia Pharmaceuticals Inc. (NASDAQ:AUPH) Q2 2025 Earnings Call TranscriptAugust 1, 2025 | msn.comAnalysts Set Expectations for AUPH Q1 EarningsAugust 1, 2025 | marketbeat.comAurinia Pharmaceuticals Inc (AUPH) Q2 2025 Earnings Call Highlights: Strong Revenue Growth and ...August 1, 2025 | gurufocus.comQ2 2025 Aurinia Pharmaceuticals Inc Earnings Call TranscriptAugust 1, 2025 | gurufocus.comAurinia (AUPH) Q2 Revenue Jumps 22%July 31, 2025 | fool.comAurinia Pharmaceuticals Inc. (AUPH) Q2 2025 Earnings Call TranscriptJuly 31, 2025 | seekingalpha.comAurinia Pharmaceuticals Reports Strong Q2 2025 Financial Results and Expands Share Repurchase PlanJuly 31, 2025 | msn.comAurinia Pharmaceuticals Inc (AUPH) Reports Strong Financial Results for Q2 2025 | AUPH stock newsJuly 31, 2025 | gurufocus.comAurinia Pharmaceuticals (NASDAQ:AUPH) Now Covered by HC WainwrightJuly 31, 2025 | marketbeat.comAurinia Pharma Q2 2025 Earnings PreviewJuly 31, 2025 | msn.comAurinia Pharmaceuticals tops Q2 estimates, raises full-year guidanceJuly 31, 2025 | za.investing.comAurinia Pharmaceuticals Reports Financial Results for the Three and Six Months Ended June 30, 2025July 31, 2025 | financialpost.comFAurinia Pharmaceuticals (AUPH) to Release Earnings on ThursdayJuly 24, 2025 | marketbeat.comAurinia Pharmaceuticals to Release Second Quarter 2025 Financial and Operational Results on July 31, 2025July 22, 2025 | financialpost.comFSegall Bryant & Hamill LLC Lowers Position in Aurinia Pharmaceuticals Inc (NASDAQ:AUPH)July 19, 2025 | marketbeat.comHussman Strategic Advisors Inc. Acquires New Position in Aurinia Pharmaceuticals Inc (NASDAQ:AUPH)July 18, 2025 | marketbeat.com225,470 Shares in Aurinia Pharmaceuticals Inc (NASDAQ:AUPH) Bought by Rice Hall James & Associates LLCJuly 15, 2025 | marketbeat.comAurinia Pharmaceuticals (NASDAQ:AUPH) Trading 8.9% Higher - Here's WhyJuly 9, 2025 | marketbeat.comAurinia Pharmaceuticals (NASDAQ:AUPH) Stock Price Passes Below 50-Day Moving Average - Here's What HappenedJuly 9, 2025 | marketbeat.comThe Play On Aurinia Pharmaceuticals: Rising Cash Flow Provides OpportunityJuly 7, 2025 | seekingalpha.comAurinia Pharmaceuticals (AUPH) Gets a Buy from TD CowenJuly 3, 2025 | theglobeandmail.comAurinia Pharmaceuticals Inc News (AUPH) - Investing.comJuly 3, 2025 | investing.comAUPH - Aurinia Pharmaceuticals Inc News - MorningstarJuly 2, 2025 | morningstar.comMAurinia Pharmaceuticals (NASDAQ:AUPH) Shares Down 8.4% - Here's What HappenedJuly 1, 2025 | marketbeat.comAurinia Announces Positive Results from Phase 1 Study of Aritinercept (AUR200)June 30, 2025 | businesswire.comAurinia Pharmaceuticals Inc (AUPH) Announces Webcast for AUR200 Phase 1 Study Results | AUPH ...June 29, 2025 | gurufocus.com Get Aurinia Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for AUPH and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. AUPH Media Mentions By Week AUPH Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. AUPH News Sentiment▼1.441.03▲Average Medical News Sentiment AUPH News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. AUPH Articles This Week▼44▲AUPH Articles Average Week Get the Latest News and Ratings for AUPH and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Aurinia Pharmaceuticals and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies LEGN News ABVX News RNA News AXSM News NUVL News MRUS News CRSP News TGTX News CYTK News ACAD News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:AUPH) was last updated on 8/28/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredThis is my Christian duty“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredWhat Are Some Strategies to Help Lower RMD Taxes?Turning 73 triggers a key IRS rule: you must begin taking required minimum distributions (RMDs) from certain r...SmartAsset | SponsoredBuffett, Gates and Bezos Quietly Dumping Stocks—Here's WhyImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | SponsoredTrump’s national nightmare is hereAI is no longer just about chatbots — it’s becoming the backbone of the global economy. While U.S. firms push ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aurinia Pharmaceuticals Inc Please log in to your account or sign up in order to add this asset to your watchlist. Share Aurinia Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access